FRA/6MK (FRA/6MK)

Frankfurt Stock Exchange: FRA/6MK · EUR

€128

+2.13 (+1.7%)· Recorded snapshot

Market cap	314B
Revenue (ttm)	58.3B
Net income (ttm)	2.8B
EPS (ttm)	€1.14
P/E (trailing)	111.8x
P/E (forward)	16.8x
Dividend	€2.94 (2.30%)
Volume	0

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 58.3B
Net income (ttm): 2.8B
EPS (ttm): €1.14
P/E (trailing): 111.8x
P/E (forward): 16.8x
Market cap: 314B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E16.8

P25 n/aP50 n/aP75 n/a

Trailing P/E111.8

P25 n/aP50 n/aP75 n/a

ROE7

P25 n/aP50 n/aP75 n/a

ROIC14.1

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All FRA/6MK indicators

Market & fundamental data

Available fields

252

Groups with data

Currency

USD

Showing 252 of 252 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	EUR
Country	United States
Country code	DE
Earnings date	2026-10-29
Employees	75,000
Employees change	0
Employees growth	0%
Enterprise value	EUR 356.1B
Exchange	Frankfurt Stock Exchange
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	1891
Industry	Drug Manufacturers - General
Is primary listing	No
ISIN number	US58933Y1055
Last earnings date	2026-08-04
Last refreshed	2026-10-28
Last stock split date	1999-02-17
Last stock split type	Forward
Market cap	EUR 314B
Next earnings date	2026-10-29
Price	EUR 127.88
Price currency	EUR
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-27
Symbol	fra/6MK
Website	https://www.merck.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	56.04x
Average P/E ratio (3Y)	100.29x
Average P/E ratio (5Y)	71.09x
Earnings yield	0.89%
EV/Earnings	128.2x
EV/EBIT	16.89x
EV/EBITDA	13.54x
EV/FCF	25.32x
EV/Sales	5.96x
FCF / EV yield	3.95%
FCF yield	4.48%
Forward P/E	16.83x
Graham number	19.51446
Graham upside	-84.74%
Lynch fair value	EUR 5.65
Lynch upside	-95.58%
P/(FCF - SBC) ratio	23.65x
P/(OCF - SBC) ratio	18.81x
P/B ratio	8.55x
P/E ratio	111.77x
P/FCF ratio	22.34x
P/OCF ratio	17.97x
P/S ratio	5.39x
Price/EBITDA ratio	12.43x
Sector forward P/E	14.8x
Sector P/E	39.91x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	35.28%
EBITDA margin	43.37%
Effective tax rate	46.72%
FCF margin	23.5%
Gross margin	75.9%
Operating margin	35.28%
Pretax margin	8.94%
Profit margin	4.77%
Profit per employee	EUR 37,531
Profitable years	35
Revenue per employee	EUR 787,403
ROA	11.87%
ROA (5Y)	11.18%
ROCE	23.01%
ROE	6.96%
ROE (5Y)	30.37%
ROIC	14.05%
ROIC (5Y)	22.36%
SBC / revenue	1.34%
Tax / revenue	4.17%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	-80.37%
EPS growth 10Y	-3.53%
EPS growth 3Y	1.25%
EPS growth 5Y	-10.38%
EPS growth years	2
FCF growth	9.11%
FCF growth (Q)	77.03%
FCF growth (QoQ)	52.96%
FCF growth 3Y	14.05%
FCF growth 5Y	18.23%
Gross profit growth	2.6%
Gross profit growth (Q)	0.52%
Gross profit growth 3Y	5.77%
Gross profit growth 5Y	9.69%
Net income growth	-80.66%
Net income growth 3Y	0.66%
Net income growth 5Y	-10.64%
Net income growth years	2
OCF growth	7.73%
OCF growth (Q)	63.07%
OCF growth (QoQ)	37.06%
OCF growth 10Y	5.83%
OCF growth 3Y	9.82%
OCF growth 5Y	10.91%
Operating income growth	-1.53%
Operating income growth 3Y	5.7%
Operating income growth 5Y	13.81%
Revenue growth	4.64%
Revenue growth (Q)	5.07%
Revenue growth (QoQ)	1.97%
Revenue growth 10Y	5.37%
Revenue growth 3Y	4.51%
Revenue growth 5Y	8.68%
Revenue growth quarters	4
Revenue growth years	6

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	EUR -3.4B
Depreciation and amortization	EUR 4.8B
EBIT	EUR 20.6B
EBITDA	EUR 25.3B
EPS	EUR 1.14
Financing cash flow	EUR 5.4B
Free cash flow	EUR 14.1B
Free cash flow minus SBC	EUR 13.3B
Gross profit	EUR 44.2B
Income taxes	EUR 2.4B
Investing cash flow	EUR -23.9B
Net borrowing	EUR 16.8B
Net cash flow	EUR -1B
Net income	EUR 2.8B
Operating cash flow minus SBC	EUR 16.7B
Operating income	EUR 20.6B
Revenue	EUR 58.3B
Stock-based compensation	EUR 780.8M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	3.6
Book value per share	EUR 14.87
Debt / EBITDA	1.84
Debt / equity	1.28
Debt / FCF	3.36
Goodwill	EUR 19.4B
Interest coverage	13.47
Long-term assets	EUR 80.6B
Long-term liabilities	EUR 51.9B
Net cash (debt)	EUR -40.9B
Net cash / market cap	-13.04%
Net debt / EBITDA	1.62
Net debt / equity	1.11
Net debt / FCF	2.91
Piotroski F-Score	4
Property, plant and equipment	EUR 23.1B
Shareholders' equity	EUR 36.7B
Tangible book value	EUR -4.1B
Tangible book value per share	EUR -1.64
Total assets	EUR 113.6B
Total cash	EUR 6.3B
Total debt	EUR 47.2B
Total liabilities	EUR 76.9B

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.54
Current assets	EUR 33B
Current liabilities	EUR 24.9B
Current ratio	1.32
Inventory turnover	2.51
Net working capital	EUR 4.1B
Quick ratio	0.74
Working capital	EUR 7.8B
Working capital turnover	5.83

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	1.92%
Dividend growth	1.02%
Dividend growth (10Y)	5.94%
Dividend growth (3Y)	2.58%
Dividend growth (5Y)	6.27%
Dividend growth years	0
Dividend payment date	2026-10-07
Dividend payment years	32
Dividend payout frequency	Quarterly
Dividend per share	EUR 2.94
Dividend yield	2.3%
Ex-dividend date	2026-09-15
Last dividend	EUR 0.74
Payout ratio	261.52%
Shareholder yield	4.21%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	127.65%
10Y return CAGR	11.94%
10Y total return	208.8%
150-day SMA	EUR 112.87
15Y price change	431.39%
15Y return CAGR	15.43%
15Y total return	760.47%
1D price change	1.69%
1M price change	-1.54%
1M total return	-1.54%
1W price change	-0.3%
1W total return	-0.3%
1Y price change	69.38%
1Y return CAGR	74.39%
1Y total return	74.33%
20-day SMA	EUR 128.72
200-day SMA	EUR 109.45
20Y price change	251.51%
20Y return CAGR	10.27%
20Y total return	605.92%
3M price change	11.2%
3M total return	11.86%
3Y price change	27.12%
3Y return CAGR	11.68%
3Y total return	39.3%
50-day SMA	EUR 128.82
50-day SMA vs 200-day SMA	50over200
52-week high	EUR 136.44
52-week high date	2026-10-22
52-week low	EUR 71.60
52-week low date	2025-11-04
5Y price change	80.83%
5Y return CAGR	16.07%
5Y total return	110.67%
6M price change	30.62%
6M total return	32.32%
All-time high	EUR 136.44
All-time high date	2026-10-22
All-time low	EUR 15.80
All-time low date	2009-03-09
Average true range (ATR)	EUR 2.58
Average volume	218.6
Change from 52-week high	-6.27%
Change from 52-week low	78.6%
Change from all-time high	-6.27%
Change from all-time low	709.37%
Change from open	1.3%
Day's gap	0.38%
High price	EUR 127.88
Low price	EUR 126.22
Monthly RSI	69.92
Open price	EUR 126.24
Position in 52-week range	100%
Previous close	EUR 125.76
Price vs 150-day SMA	13.3%
Price vs 20-day SMA	-0.65%
Price vs 200-day SMA	16.84%
Price vs 50-day SMA	-0.73%
Relative volume	0.32
RSI	48.62
Sharpe ratio	1.86
Sharpe ratio (3Y)	0.44
Sharpe ratio (5Y)	0.5
Sortino ratio	3.43
Sortino ratio (3Y)	0.86
Sortino ratio (5Y)	0.96
Volume	0
Weekly RSI	62.41
YTD price change	41.62%
YTD total return	44.52%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	2.5B
Shares change (QoQ)	-0.08%
Shares change (YoY)	-1.92%
Shares held by insiders	0.05%
Shares held by institutions	81.18%
Short ratio	2.6 days

Deeper analysis on FRA/6MK

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this FRA/6MK report

Is a complete FRA/6MK research report available?

No complete published report is available for fra/6MK (FRA/6MK) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

FRA/6MK (FRA/6MK)

Price

Financial snapshot

Fair-value bridge

Latest news · FRA/6MK

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All FRA/6MK indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on FRA/6MK

Frequently asked questions